Gallagher Publishes OpEd in The Hill on the USMCA
GDP Center Director Kevin Gallagher outlines how the pharmaceutical industry will benefit from the U.S.-Mexico-Canada Agreement (USMCA).
GDP Center Director Kevin Gallagher outlines how the pharmaceutical industry will benefit from the U.S.-Mexico-Canada Agreement (USMCA).